Market Overview

Pharmacy Times Continuing Education™ Presents a Live Broadcast on Chronic Lymphocytic Leukemia

Share:

The live webinar will feature expert clinical and oncology
pharmacists from Indiana University Health

Pharmacy Times Continuing Education™ (PTCE), a leader in
continuing education for retail, health-system, managed care and
specialty pharmacists, will host the live video broadcast "Novel
Immunotherapy Options for the Long-term Care of Patients with Chronic
Lymphocytic Leukemia (CLL): The Role of Clinical and Specialty
Pharmacists." The webinar will take place Tuesday, September 18, at 7
p.m. ET.

"Clinical advances in CLL have improved patient outcomes, but often
involve complex treatment strategies that require collaboration between
clinical and specialty pharmacists," said Jim Palatine, RPh, MBA,
president of PTCE. "We are thrilled to have the resources
to present this interactive, discussion-based broadcast on the
importance of integrating new and emerging CLL agents into the current
treatment paradigm to enhance patient care live to our participants.
Clinical and specialty pharmacists need to stay up-to-date on the
ever-changing landscape of CLL management, and this live broadcast will
offer them a great opportunity to interact with experts on a topic of
critical importance."

Faculty presenters for the webinar include:

  • Christopher A. Fausel, PharmD, MHA, BCOP, clinical
    manager, oncology pharmacy, Indiana University Health; chairman of the
    board, Hoosier Cancer Research Network
  • Julianne Orr, PharmD, BCOP, outpatient oncology clinical
    pharmacist, department of pharmacy, Indiana University Health Simon
    Cancer Center

With the expertise of faculty, this webinar will illustrate current and
novel treatments for CLL and highlight the importance of integrating
these agents into treatment paradigms. The presenters will also discuss
the role of BCR-associated kinases, such as Bruton tyrosine kinase and
phosphoinositide 3-kinase, and other inhibitors of BCR signaling in CLL
treatment. Additionally, participants will learn strategies to manage
and counsel patients with CLL.

This activity is supported by educational grants from Pharmacyclics LLC.
An AbbVie company; Janssen Biotech, Inc.; and CURE Media Group.

PTCE is accredited by the Accreditation Council for Pharmacy
Education as a provider of continuing pharmacy education. Attendees are
eligible to earn 1.5 contact hours (0.15 CEU). For registration and more
information, visit https://www.pharmacytimes.org/live/immunotherapy-options-longterm-care-cll.

About Pharmacy Times Continuing Education™

Pharmacy Times Continuing Education™ (PTCE) is a
leader in continuing education for retail, health-system, managed care
and specialty pharmacists. PTCE is accredited by the
Accreditation Council for Pharmacy Education as a provider of continuing
pharmacy education (CPE). PTCE's print, online and live CPE
activities are designed to help improve the knowledge, competence and
skills of pharmacists so that they are better prepared to provide the
highest quality of pharmacy care to the patients they serve and to the
physicians they assist as part of a multidisciplinary
treatment/management team. To learn more about the educational
activities sponsored by PTCE, visit https://www.pharmacytimes.org/.

View Comments and Join the Discussion!